Used in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It plays a role in developing compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structure supports binding selectivity to specific nAChR subtypes, making it valuable in creating more effective and targeted therapies. Also employed in the development of radiolabeled derivatives for use in positron emission tomography (PET) imaging to study receptor distribution in the brain.